These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 25770113)

  • 1. Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    BMJ; 2015 Mar; 350():h1269. PubMed ID: 25770113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of liver injury among methotrexate users: A meta-analysis of randomised controlled trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    Semin Arthritis Rheum; 2015 Oct; 45(2):156-62. PubMed ID: 26088004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leflunomide Use and Risk of Lung Disease in Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis of Randomized Controlled Trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    J Rheumatol; 2016 May; 43(5):855-60. PubMed ID: 26980577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACP Journal Club. Review: Methotrexate does not increase risk for lung disease in psoriasis, psoriatic arthritis, or IBD.
    Smith MD
    Ann Intern Med; 2015 Jul; 163(2):JC7. PubMed ID: 26192587
    [No Abstract]   [Full Text] [Related]  

  • 5. Methotrexate and lung disease in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    Arthritis Rheumatol; 2014 Apr; 66(4):803-12. PubMed ID: 24757133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of folic or folinic acid supplementation on methotrexate-associated safety and efficacy in inflammatory disease: a systematic review.
    Prey S; Paul C
    Br J Dermatol; 2009 Mar; 160(3):622-8. PubMed ID: 18945303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Efficacy of Methotrexate for Chinese Adults With Psoriasis With and Without Psoriatic Arthritis.
    Yan K; Zhang Y; Han L; Huang Q; Zhang Z; Fang X; Zheng Z; Yawalkar N; Chang Y; Zhang Q; Jin L; Qian D; Li X; Wu M; Xu Q; Zhang X; Xu J
    JAMA Dermatol; 2019 Mar; 155(3):327-334. PubMed ID: 30698628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation.
    Corbett M; Chehadah F; Biswas M; Moe-Byrne T; Palmer S; Soares M; Walton M; Harden M; Ho P; Woolacott N; Bojke L
    Health Technol Assess; 2017 Oct; 21(56):1-326. PubMed ID: 28976302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methotrexate use in psoriasis and psoriatic arthritis.
    Cuellar ML; Espinoza LR
    Rheum Dis Clin North Am; 1997 Nov; 23(4):797-809. PubMed ID: 9361156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apremilast (Otezla). No progress in plaque psoriasis or psoriatic arthritis.
    Prescrire Int; 2016 Jun; 25(172):149-51. PubMed ID: 27486641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are biologics combined with methotrexate better than biologics monotherapy in psoriasis and psoriatic arthritis: A meta-analysis of randomized controlled trials.
    Xie Y; Liu Y; Liu Y
    Dermatol Ther; 2021 May; 34(3):e14926. PubMed ID: 33655646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic therapy of psoriasis: methotrexate.
    Kozub P; Simaljakova M
    Bratisl Lek Listy; 2011; 112(7):390-4. PubMed ID: 21744734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
    Pincus T; Bergman MJ; Yazici Y
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials.
    West J; Ogston S; Foerster J
    PLoS One; 2016; 11(5):e0153740. PubMed ID: 27168193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative risk of and determinants for adverse events of methotrexate prescribed at a low dose: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Mazaud C; Fardet L
    Br J Dermatol; 2017 Oct; 177(4):978-986. PubMed ID: 28182264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and lung disease in rheumatoid arthritis.
    Conway R; Carey JJ
    Panminerva Med; 2017 Mar; 59(1):33-46. PubMed ID: 27711025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Low-Dose Methotrexate Exposure and Melanoma: A Systematic Review and Meta-analysis.
    Yan MK; Wang C; Wolfe R; Mar VJ; Wluka AE
    JAMA Dermatol; 2022 Oct; 158(10):1157-1166. PubMed ID: 36044236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
    Gordon KB; Ruderman EM
    J Am Acad Dermatol; 2006 Mar; 54(3 Suppl 2):S85-91. PubMed ID: 16488334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate in psoriatic arthritis.
    Singh YN; Verma KK; Kumar A; Malaviya AN
    J Assoc Physicians India; 1994 Nov; 42(11):860-2. PubMed ID: 7868484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.